한글목차

세계의 지혈 스프레이 시장 규모는 2025년에는 29억 9,000만 달러로 추정되고, 2032년에는 55억 7,000만 달러에 이를 것으로 예측되며, 2025-2032년의 CAGR은 9.3%를 나타낼 전망입니다.

지혈 스프레이는 수술 중 및 응급 상황에서 출혈을 제어하는 데 도움이 되는 중요한 의료 기술 혁신입니다. 빠르고 효율적으로 출혈을 멈추도록 설계되었습니다. 지혈 스프레이는 수술 중이나 응급시 지혈에 사용되는 의료 제품입니다. 보통 트롬빈이나 피브리노겐 등 응고를 촉진하는 물질이 포함되며, 콜라겐이나 젤라틴 등 조직에의 접착을 돕는 물질이 포함될 수도 있습니다. 또는 전용 장치를 통해 출혈 부위에 직접 도포합니다. 지혈 스프레이는 수술, 응급 의료, 외상 치료 등 다양한 의료 현장에서 사용되고 있습니다. 전통적인 지혈 방법이 효과적이지 않고 실용적이지 않은 경우 특히 유용합니다. 지혈 스프레이 기술의 진보 등의 요인이 있습니다.세계의 지혈 스프레이 시장에 있어서의 주요한 시장 기업에는 박스터 인터내셔널, CR버드, 존슨·엔드·존슨 등, 이러한 제품을 제조·판매하는 기업이 포함됩니다. 이 기업은 지혈 스프레이의 유효성과 안전성을 향상시키고

시장 역학 :

규제 당국의 제품 승인 증가는 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다.

또한 시장에는 수많은 성장 기회가 있습니다. 지혈 스프레이 제형의 진보와 혁신적인 전달 시스템의 개발은 시장 확대의 가능성을 지니고 있습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 지혈 스프레이 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모와 CAGR%를 제공합니다.
• 또한 다양한 부문에서 잠재적인 수익 기회를 밝혀 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 파라미터를 바탕으로 세계의 지혈 스프레이 시장 주요 기업 프로파일을 제공합니다.
• 본 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 향후 제품 발매, 유형의 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 세계의 지혈 스프레이 시장 보고서는 투자자, 공급자, 제품 제조업체, 유통업체, 신규 참가자, 재무 애널리스트 등, 이 업계의 다양한 이해 관계자에 대응하고 있습니다.
• 이해관계자는 세계의 지혈 스프레이 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 수술 건수 증가
  • 엄격한 규제 정책
  • 낮은 침습 수술에서 사용 증가
• 주요 하이라이트
• 규제 시나리오
• 최근 동향
• 제품 출시/승인
• PEST 분석
• Porter's Five Forces 분석
• 합병, 인수, 제휴

제4장 세계의 지혈 스프레이 시장 : COVID-19 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 지혈 스프레이 시장 : 제품 유형별(2020-2032년)

• 젤라틴 베이스
• 콜라겐 베이스
• 셀룰로오스 베이스
• 키토산 베이스
• 복합지혈제
• 기타

제6장 세계의 지혈 스프레이 시장 : 용도별(2020-2032년)

• 외상 치료
• 일반 수술
• 혈관 수술
• 심장 수술
• 성형외과
• 정형외과
• 신경외과

제7장 세계의 지혈 스프레이 시장 : 최종 사용자별(2020-2032년)

• 병원
• 외래수술센터(ASC)
• 전술 전투 부상자 케어 센터
• 기타

제8장 세계의 지혈 스프레이 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙 아프리카
  • 남아프리카

제9장 경쟁 구도

• 기업 프로파일
  • Olympus Corporation
  • Medtronic plc
  • Shilpa Medicare Limited
  • Baxter
  • BC3 Technologies
  • Ethicon
  • Pfizer Inc.
  • HemCon Medical Technologies
  • Z-Medica
  • Teleflex Incorporated
  • Tricol Biomedical
  • Arch Therapeutics
  • Cook

제10장 섹션

• 참고문헌
• 조사 방법
• 출판사에 대해

영문목차

Hemostatic Spray Market is estimated to be valued at USD 2.99 Bn in 2025 and is expected to reach USD 5.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Hemostatic sprays are a vital medical innovation that aids in the control of bleeding during surgical procedures or in emergency situations. These sprays are designed to quickly and efficiently stop bleeding by promoting clot formation and thus creating a protective barrier over the wound. Hemostatic sprays have gained immense popularity in the healthcare industry due to their ease of use, effectiveness, and ability to minimize blood loss, thereby reducing the need for blood transfusions. Hemostatic spray is a medical product used to stop bleeding during surgical procedures or in emergency situations. It works by forming a layer over the bleeding area, which helps to clot the blood and stop the bleeding. The spray typically contains a substance that promotes clotting, such as thrombin or fibrinogen, and may also contain a substance to help adhere to the tissue, such as collagen or gelatin. The spray is applied directly to the bleeding area, either through a spray canister or a specialized device. Hemostatic sprays are used in a variety of medical settings, including surgery, emergency medicine, and trauma care. They are particularly useful in situations where traditional methods of controlling bleeding, such as sutures or staples, are not effective or practical. The global market for hemostatic sprays is increasing, which is driven by factors such as the increasing number of surgical procedures, the rising prevalence of chronic diseases that require surgery, and advancements in hemostatic spray technology. Key market players in the global hemostatic spray market include companies that manufacture and distribute these products, such as Baxter International, C.R. Bard, and Johnson & Johnson. These companies are investing in research and development (R&D) to improve the efficacy and safety of hemostatic sprays and to expand their applications.

Market Dynamics:

Increasing product approval by the regulatory bodies is expected to drive the growth of the market over the forecast period. For instance, in September 2022, Shilpa Medicare Limited, a medical device company, announced the Central Drugs Standard Control Organisation (CDSCO) approval of its hemostatic spray.

Despite these challenges, the market presents numerous opportunities for growth. Advancements in hemostatic spray formulations and the development of innovative delivery systems have the potential to expand the market. Moreover, the introduction of government initiatives to improve healthcare infrastructure, particularly in emerging economies, will likely boost the demand for hemostatic sprays.

Key features of the study:

• This report provides in-depth analysis of the global hemostatic spray market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hemostatic spray market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Olympus Corporation, Medtronic plc., Shilpa Medicare Limited, Baxter, BC3 Technologies, Ethicon, Pfizer Inc., HemCon Medical Technologies, Z-Medica, Teleflex Incorporated, Tricol Biomedical, Arch Therapeutics, and Cook
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global hemostatic spray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemostatic spray market

Global Hemostatic Spray Market Detailed Segmentation:

• By Product Type
  • Gelatin Based
  • Collagen Based
  • Cellulose Based
  • Chitosan Based
  • Combination Hemostats
  • Others
• By Application
  • Trauma Care
  • General Surgery
  • Vascular Surgery
  • Cardiac Surgery
  • Plastic Surgery
  • Orthopedic Surgery
  • Neurosurgery
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Tactical Combat Casualty Care Centers
  • Others
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Olympus Corporation
  • Medtronic plc.
  • Shilpa Medicare Limited
  • Baxter
  • BC3 Technologies
  • Ethicon
  • Pfizer Inc.
  • HemCon Medical Technologies
  • Z-Medica
  • Teleflex Incorporated
  • Tricol Biomedical
  • Arch Therapeutics
  • Cook

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing number of surgeries
  • Stringent regulatory policies
  • Increasing use in minimally invasive surgeries
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Hemostatic Spray Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Hemostatic Spray Market, By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Gelatin Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Collagen Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cellulose Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Chitosan Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Combination Hemostat
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Hemostatic Spray Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Trauma Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• General Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Vascular Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cardiac Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Plastic Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Orthopedic Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neurosurgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Hemostatic Spray Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tactical Combat Casualty Care Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Hemostatic Spray Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth. By Country, 2020 - 2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profile
  • Olympus Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Shilpa Medicare Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Baxter
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BC3 Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ethicon
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• HemCon Medical Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Z-Medica
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Tricol Biomedical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Arch Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Cook
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• References
• Research Methodology
• About us